OncoSec Medical Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and OncoSec Medical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days OncoSec Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, OncoSec Medical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 46 M | |
| Total Cashflows From Investing Activities | -244.9 K |
OncoSec |
OncoSec Medical Relative Risk vs. Return Landscape
If you would invest (100.00) in OncoSec Medical on November 26, 2025 and sell it today you would earn a total of 100.00 from holding OncoSec Medical or generate -100.0% return on investment over 90 days. OncoSec Medical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than OncoSec, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
OncoSec Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OncoSec Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OncoSec Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OncoSec Medical is not yet fully synchronised with the market data | |
| OncoSec Medical has some characteristics of a very speculative penny stock | |
| OncoSec Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OncoSec Medical currently holds about 19.48 M in cash with (32.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders |
OncoSec Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OncoSec Stock often depends not only on the future outlook of the current and potential OncoSec Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OncoSec Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.8 M | |
| Cash And Short Term Investments | 12.3 M |
OncoSec Medical Fundamentals Growth
OncoSec Stock prices reflect investors' perceptions of the future prospects and financial health of OncoSec Medical, and OncoSec Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OncoSec Stock performance.
| Return On Equity | -4.1 | |||
| Return On Asset | -0.93 | |||
| Current Valuation | 5.6 M | |||
| Shares Outstanding | 5.96 M | |||
| Price To Earning | (3.12) X | |||
| Price To Book | 0.78 X | |||
| EBITDA | (35.92 M) | |||
| Cash And Equivalents | 19.48 M | |||
| Cash Per Share | 0.50 X | |||
| Total Debt | 6.17 M | |||
| Debt To Equity | 0.76 % | |||
| Book Value Per Share | (1.85) X | |||
| Cash Flow From Operations | (32.14 M) | |||
| Earnings Per Share | (20.31) X | |||
| Total Asset | 21.88 M | |||
| Retained Earnings | (285.96 M) | |||
| Current Asset | 29.42 M | |||
| Current Liabilities | 3.47 M | |||
Things to note about OncoSec Medical performance evaluation
Checking the ongoing alerts about OncoSec Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OncoSec Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OncoSec Medical is not yet fully synchronised with the market data | |
| OncoSec Medical has some characteristics of a very speculative penny stock | |
| OncoSec Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OncoSec Medical currently holds about 19.48 M in cash with (32.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing OncoSec Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OncoSec Medical's stock is overvalued or undervalued compared to its peers.
- Examining OncoSec Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OncoSec Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OncoSec Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OncoSec Medical's stock. These opinions can provide insight into OncoSec Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |